浅析TAC和TP方案用于三阴性乳腺癌患者治疗中的临床效果

目的对TAC和TP方案治疗三阴性乳腺癌的临床疗效进行分析.方法：抽取2013年02月-2015年04月我院收治的102例三阴性乳腺癌患者随机分成研究组和对比组,两组各有51例患者,其中51例对比组患者给予TP方案治疗,51例研究组患者给予TAC方案治疗,对两组患者的治疗效果进行比较.结果：研究组患者的近期治疗效果与不良反应与对比组患者并无太大的差异,治疗效果数据对比差异不明显（P〈0.05）.结论：采用TAC和TP两种化疗方案对三阴性乳腺癌患者进行治疗效果相当,不良反应症状都在患者可承受的范围内.

Objective three negative of TAC and TP regimen for breast cancer clinical efficacy were analyzed. Method： to extract 02, 2013-04, 2015 of our hospital, 102 cases of three negative breast cancer patients randomly divided into research group and the control group, two groups have 51 patients, including 51 cases, control group patients give TP regimen for 51 patients with team TAC solution was given to compare the effect of two groups of patients. Results： the team in patients with recent therapeutic effects and adverse reactions and contrast group of patients is not too big difference, treatment effect comparison is not obvious difference （P 〈 0.05）. Conclusion： using both TAC and TP chemotherapy regimens for three negative effect of breast cancer patients treated fairly, adverse symptoms in patients with affordable range.